Cryo-Cell Intl Inc (CCEL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 11/30
(Values in U.S. thousands)
| 11-2025 | 08-2025 | 05-2025 | 02-2025 | 11-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,429 | 1,388 | 639 | 283 | 402 |
| Depreciation Amortization | 1,389 | 1,054 | 695 | 345 | 1,043 |
| Income taxes - deferred | -2,819 | N/A | N/A | N/A | -309 |
| Accounts receivable | -406 | -305 | 11 | -174 | -2,000 |
| Accounts payable and accrued liabilities | 1,000 | 741 | 371 | 735 | -424 |
| Other Working Capital | 2,838 | -51 | -835 | -274 | 3,698 |
| Other Operating Activity | 5,905 | 1,371 | 781 | 39 | 3,600 |
| Operating Cash Flow | $5,479 | $4,198 | $1,661 | $954 | $6,011 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -116 | -48 | -10 | -62 | -2,404 |
| Purchase Of Investment | -3,648 | -3,160 | -2,574 | -600 | -2,891 |
| Sale Of Investment | 2,788 | 2,523 | 793 | 374 | 1,618 |
| Purchase Sale Intangibles | N/A | N/A | N/A | N/A | -1,200 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -1,200 |
| Investing Cash Flow | $-975 | $-686 | $-1,790 | $-288 | $-4,877 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 8,800 | 6,800 | 6,800 | 2,800 | 5,220 |
| Debt Repayment | -148 | -110 | -74 | -34 | -136 |
| Common Stock Issued | 23 | 23 | N/A | N/A | 76 |
| Common Stock Repurchased | -170 | -170 | -89 | N/A | -1,424 |
| Dividend Paid | -3,231 | -3,231 | -3,231 | -2,021 | -2,021 |
| Other Financing Activity | -10,020 | -7,120 | -3,700 | -1,750 | -2,695 |
| Financing Cash Flow | $-4,745 | $-3,808 | $-294 | $-1,004 | $-979 |
| Beginning Cash Position | 561 | 561 | 561 | 561 | 406 |
| End Cash Position | 319 | 265 | 138 | 223 | 561 |
| Net Cash Flow | $-242 | $-296 | $-424 | $-338 | $155 |
| Free Cash Flow | |||||
| Operating Cash Flow | 5,479 | 4,198 | 1,661 | 954 | 6,011 |
| Capital Expenditure | -231 | -163 | -125 | -62 | -2,404 |
| Free Cash Flow | 5,248 | 4,035 | 1,537 | 892 | 3,607 |